Konsuld™, a leader in AI-enriched clinical collaboration, is pleased to announce the appointment of Stefan Glück, MD, PhD, FRCPC, as its new Chief Medical Officer. Dr. Glück brings decades of distinguished experience in oncology, solid tumor research, and immuno-oncology to his new role.
Dr. Glück has served in multiple prestigious academic and clinical roles, including as Sylvester Professor at the Leonard M. Miller School of Medicine at the University of Miami and Clinical Director at the Braman Family Breast Cancer Institute. Prior to his time at the University of Miami, he led the Southern Alberta Breast Cancer Program at the Tom Baker Cancer Centre, and held leadership positions at the University of Calgary’s Departments of Oncology, Medicine, and Pharmacology.
Widely respected for his clinical acumen and research contributions, Dr. Glück has authored over 200 peer-reviewed publications and has been a recognized thought leader in oncology for over two decades. He has been honored as one of America’s Top Oncologists and was consistently named among the Best Doctors in America from 2006 through 2012.
“We are thrilled to welcome Dr. Glück to the Konsuld team,” said Jan Heybroek, Konsuld’s Chief Executive Officer.. “His unparalleled expertise in clinical oncology and his commitment to advancing patient care through innovative solutions align perfectly with Konsuld’s mission to elevate clinical collaboration and patient outcomes through AI.”
“The reason I joined Konsuld,” states Dr. Glück in his LinkedIn post, “is that it will change how physicians and other healthcare providers will seek help online. Konsuld with AI will enable them to get the best possible information quickly and reliably so they can help patients even more effectively. As a physician, oncologist, hematologist, and clinical researcher, it is very exciting to see myself be a part of Konsuld and thus indirectly still help patients.”
Dr. Glück’s appointment will support Konsuld’s strategic growth in AI-driven healthcare, strengthening its mission to provide actionable insights and enhanced collaboration for healthcare providers and life sciences professionals.
About Konsuld
Konsuld is a pioneering healthcare technology company specializing in AI-enriched clinical collaboration to improve patient care and streamline decision-making for medical providers and researchers. The platform combines clinical data, AI insights, and expert knowledge to transform how healthcare teams operate and optimize patient outcomes.
